A randomised study comparing performance and safety of eyestil plus® vs vismed multi® in moderate-to-severe dry eye syndrome patients

dc.contributor.author	Pisella, P. J.
dc.contributor.author	Gain, P.
dc.contributor.author	Cochener, B.
dc.contributor.author	Merayo Lloves, Jesús
dc.contributor.author	(et al.)
dc.date.accessioned	2025-02-07T07:21:14Z
dc.date.available	2025-02-07T07:21:14Z
dc.date.issued	2024
dc.identifier.citation	European Journal of Ophthalmology (2024); doi:10.1177/11206721241266874
dc.identifier.issn	1120-6721
dc.identifier.uri	https://hdl.handle.net/10651/76702
dc.description.sponsorship	The present clinical investigation has been funded and sponsored by SIFI S.p.A (Italy).
dc.language.iso	eng
dc.relation.ispartof	European Journal of Ophthalmology
dc.rights	©,
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85200329877&doi=10.1177%2f11206721241266874&partnerID=40&md5=cc6852354f234f987e5b23caeded133e
dc.title	A randomised study comparing performance and safety of eyestil plus® vs vismed multi® in moderate-to-severe dry eye syndrome patients
dc.type	journal article
dc.identifier.doi	10.1177/11206721241266874
dc.relation.publisherversion	http://dx.doi.org/10.1177/11206721241266874

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.